CM Shinde presents Ratan Tata with ‘Udyog Ratna’, calls him an institution

Maharashtra Chief Minister Eknath Shinde on Sunday hailed industrialist Ratan Tata, the first-ever recipient of the ‘Udyog Ratna’ award instituted by the state government, as an “institution”.
Shinde also said industries in Maharashtra are the main strength of the growth engine.
He was speaking at the Udyog Puraskar 2023 distribution ceremony here where he praised Ratan Tata.
The ‘Udyog Ratna’ award was presented to the 85-year-old chairman emeritus of Tata Sons by Shinde and Deputy CMs Devendra Fadnavis and Ajit Pawar at the industrialist’s home in south Mumbai on Saturday.
On Sunday, Adar Poonawalla of Serum Institute was honoured with the Udyog Mitra award while the Udyogini award was given to Gauri Kirloskar. The best Marathi businessman award was bestowed upon Vilas Shinde, the MD of Sahyadri Farmers’ Producers Company.
None of us have seen God, but it is believed that God is everywhere. We have selected a ‘dev manoos’ (Godly person) like Ratan Tata for the (first ever) Udyog Ratna award. Tata means trust and quality assurance, and the company has always demonstrated its social connect, the chief minister said.
Industries in Maharashtra are the main strength of the growth engine. The state has thus decided to acknowledge the contribution of the industries through such awards, Shinde said.
The chief minister said he signed investment agreements worth Rs 1.37 lakh crore during his visit to Davos last year.
“Out of them, 85 per cent of agreements have progressed further. Maharashtra has once again topped the chart of attracting FDI (Foreign Direct Investments), he claimed.
Shinde said all industries, traders, businessmen and various chambers of commerce should form a high-power committee to prepare a blueprint for the next 25 years of the state’s progress.

Related Posts

  • Pharma
  • July 8, 2024
  • 68 views
Respiratory, Malaria Drug Demand Rises As Monsoon Sets

New Delhi: The onset of monsoon boosted sales of drugs for respiratory, anti-infective, anti-malaria and gastrointestinal therapies in June. According to market researcher Pharmarack, these therapies saw a double-digit growth…

  • Pharma
  • July 8, 2024
  • 82 views
MDC To Seek Clarity On Licensing Requirement For Drug Device Combination

New Delhi: The Multidisciplinary Committee of Experts (MDC), which advices the National Pharmaceutical Pricing Authority (NPPA), will be seeking clarity from the central drug regulator on the licensing requirement of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Respiratory, Malaria Drug Demand Rises As Monsoon Sets

Respiratory, Malaria Drug Demand Rises As Monsoon Sets

MDC To Seek Clarity On Licensing Requirement For Drug Device Combination

MDC To Seek Clarity On Licensing Requirement For Drug Device Combination

Police Seized 500 Cough Syrup & 1200 Sedative Injections In Bargarh

Police Seized 500 Cough Syrup & 1200 Sedative Injections In Bargarh

Domestic MedTech Industry’s Expectations from upcoming Modi 3.0 Union Budget

Domestic MedTech Industry’s Expectations from upcoming Modi 3.0 Union Budget

Gym Owner Held For Selling Steroids

Gym Owner Held For Selling Steroids

Dr Reddy’s, Sun Pharma Recall Drugs In US Due To Manufacturing Issues

Dr Reddy’s, Sun Pharma Recall Drugs In US Due To Manufacturing Issues